Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting.
Tasamma AT, Bukate TA, Mehadi A, Handiso BT, Kassa BY, Hassen EO, Ayalew ZS, Tegegne DH, Azibte GT, Zewdie TA, Shihur TZ, Geremamo YD, Mesfin YD, Alemayehu RM, Asefa AK, Abdela F, Melkie A.
Tasamma AT, et al. Among authors: ayalew zs.
Cancer Rep (Hoboken). 2025 Jan;8(1):e70105. doi: 10.1002/cnr2.70105.
Cancer Rep (Hoboken). 2025.
PMID: 39846434
Free PMC article.